156 related articles for article (PubMed ID: 37930420)
21. Effects of novel flash glucose monitoring system on glycaemic control in adult patients with type 1 diabetes mellitus: protocol of a multicentre randomised controlled trial.
Zhou Y; Deng H; Liu H; Yang D; Xu W; Yao B; Yan J; Weng J
BMJ Open; 2020 Dec; 10(12):e039400. PubMed ID: 33277281
[TBL] [Abstract][Full Text] [Related]
22. Effects of flash glucose monitoring on glycemic control in participants with diabetes mellitus: A meta-analysis of randomized controlled trials.
Gao Y; Zhou M; Xu X; Chen WY
J Diabetes Complications; 2022 Nov; 36(11):108314. PubMed ID: 36208566
[TBL] [Abstract][Full Text] [Related]
23. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4).
Fokkert M; van Dijk P; Edens M; Barents E; Mollema J; Slingerland R; Gans R; Bilo H
BMJ Open Diabetes Res Care; 2019; 7(1):e000809. PubMed ID: 31875133
[TBL] [Abstract][Full Text] [Related]
24. Time in range-A1c hemoglobin relationship in continuous glucose monitoring of type 1 diabetes: a real-world study.
Valenzano M; Cibrario Bertolotti I; Valenzano A; Grassi G
BMJ Open Diabetes Res Care; 2021 Jan; 9(1):. PubMed ID: 33514530
[TBL] [Abstract][Full Text] [Related]
25. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
[TBL] [Abstract][Full Text] [Related]
26. Intermittently Scanned Glucose Values for Continuous Monitoring: Cross-Sectional Analysis of Glycemic Control and Hypoglycemia in 1809 Children and Adolescents with Type 1 Diabetes.
Biester T; Grimsmann JM; Heidtmann B; Rami-Merhar B; Ermer U; Wolf J; Freff M; Karges B; Agena D; Bramlage P; Danne T; Holl RW
Diabetes Technol Ther; 2021 Mar; 23(3):160-167. PubMed ID: 33084351
[No Abstract] [Full Text] [Related]
27. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B
Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500
[TBL] [Abstract][Full Text] [Related]
28. Factors influencing the effectiveness of using flash glucose monitoring on glycemic control for type 1 diabetes in Saudi Arabia.
Alhodaib HI; Alsulihem S
World J Diabetes; 2021 Nov; 12(11):1908-1916. PubMed ID: 34888015
[TBL] [Abstract][Full Text] [Related]
29. FGM-based remote intervention for adults with type 1 diabetes: The FRIEND randomized clinical trial.
Lee J; Lee MH; Park J; Kim KS; Kim SK; Cho YW; Han HW; Song YS
Front Endocrinol (Lausanne); 2022; 13():1054697. PubMed ID: 36506077
[TBL] [Abstract][Full Text] [Related]
30. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
[TBL] [Abstract][Full Text] [Related]
31. Glycemic Variability Is Associated with Frequency of Blood Glucose Testing and Bolus: Post Hoc Analysis Results from the ProAct Study.
Pfützner A; Weissmann J; Mougiakakou S; Daskalaki E; Weis N; Ziegler R
Diabetes Technol Ther; 2015 Jun; 17(6):392-7. PubMed ID: 25734860
[TBL] [Abstract][Full Text] [Related]
32. Lower Glycated Hemoglobin with Real-Time Continuous Glucose Monitoring Than with Intermittently Scanned Continuous Glucose Monitoring After 1 Year: The CORRIDA LIFE Study.
Radovnická L; Hásková A; Do QD; Horová E; Navrátilová V; Mikeš O; Cihlář D; Parkin CG; Grunberger G; Prázný M; Šoupal J
Diabetes Technol Ther; 2022 Dec; 24(12):859-867. PubMed ID: 36037056
[No Abstract] [Full Text] [Related]
33. Glycemic control after switching to faster aspart in adults with type 1 diabetes.
Fadini GP; Boscari F; Falaguasta D; Ferretto S; Maran A; Avogaro A; Bruttomesso D
J Endocrinol Invest; 2022 Jun; 45(6):1181-1188. PubMed ID: 35103951
[TBL] [Abstract][Full Text] [Related]
34. Association between Flash Glucose Monitoring and Metabolic Control as well as Treatment Satisfaction in Outpatients With Diabetes Type 1.
Kramer G; Michalak L; Müller UA; Kloos C; Werner C; Kuniss N
Exp Clin Endocrinol Diabetes; 2021 Mar; 129(4):303-308. PubMed ID: 31185506
[TBL] [Abstract][Full Text] [Related]
35. Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial.
Secher AL; Pedersen-Bjergaard U; Svendsen OL; Gade-Rasmussen B; Almdal T; Raimond L; Vistisen D; Nørgaard K
Diabetologia; 2021 Dec; 64(12):2713-2724. PubMed ID: 34495375
[TBL] [Abstract][Full Text] [Related]
36. Glucose Awareness to Motivate and Enable Solutions (GAMES) in diabetes mellitus using flash glucose monitoring: A clinical programme.
Yeoh E; Png D; Koh PL; Sum CF; Lim SC; Tan HH; Ubeynarayana CU; Subramaniam T
Diabet Med; 2022 Jan; 39(1):e14733. PubMed ID: 34698420
[TBL] [Abstract][Full Text] [Related]
37. Two-year use of flash glucose monitoring is associated with sustained improvement of glycemic control and quality of life (FLARE-NL-6).
Lameijer A; Fokkert MJ; Edens MA; Gans ROB; Bilo HJG; van Dijk PR
BMJ Open Diabetes Res Care; 2021 Sep; 9(1):. PubMed ID: 34521652
[TBL] [Abstract][Full Text] [Related]
38. Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls.
Nathanson D; Svensson AM; Miftaraj M; Franzén S; Bolinder J; Eeg-Olofsson K
Diabetologia; 2021 Jul; 64(7):1595-1603. PubMed ID: 33774713
[TBL] [Abstract][Full Text] [Related]
39. Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes.
Fernández E; Cortazar A; Bellido V
Diabetes Res Clin Pract; 2020 Aug; 166():108348. PubMed ID: 32711000
[TBL] [Abstract][Full Text] [Related]
40. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study.
Reddy M; Jugnee N; Anantharaja S; Oliver N
Diabetes Technol Ther; 2018 Nov; 20(11):751-757. PubMed ID: 30265562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
